HealthEquity, Inc. (NASDAQ:HQY) Shares Sold by Alberta Investment Management Corp

Alberta Investment Management Corp reduced its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 41.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 12,346 shares of the company’s stock after selling 8,842 shares during the period. Alberta Investment Management Corp’s holdings in HealthEquity were worth $1,185,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also bought and sold shares of HQY. UMB Bank n.a. boosted its holdings in HealthEquity by 65.6% in the 4th quarter. UMB Bank n.a. now owns 414 shares of the company’s stock valued at $40,000 after purchasing an additional 164 shares during the last quarter. Quarry LP raised its position in HealthEquity by 418.8% in the third quarter. Quarry LP now owns 1,349 shares of the company’s stock valued at $110,000 after purchasing an additional 1,089 shares during the period. 1620 Investment Advisors Inc. acquired a new position in shares of HealthEquity in the 3rd quarter valued at $112,000. GAMMA Investing LLC grew its holdings in shares of HealthEquity by 32.9% during the 4th quarter. GAMMA Investing LLC now owns 1,248 shares of the company’s stock worth $120,000 after purchasing an additional 309 shares during the period. Finally, Covestor Ltd raised its holdings in HealthEquity by 27.4% in the 3rd quarter. Covestor Ltd now owns 1,524 shares of the company’s stock valued at $125,000 after buying an additional 328 shares during the period. 99.55% of the stock is owned by hedge funds and other institutional investors.

HealthEquity Price Performance

Shares of HQY opened at $108.60 on Friday. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. HealthEquity, Inc. has a fifty-two week low of $65.01 and a fifty-two week high of $115.59. The firm has a 50-day simple moving average of $103.66 and a 200-day simple moving average of $92.05. The company has a market capitalization of $9.41 billion, a price-to-earnings ratio of 99.63, a price-to-earnings-growth ratio of 1.63 and a beta of 0.55.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings data on Monday, December 9th. The company reported $0.59 earnings per share for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.12). HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same period last year, the firm earned $0.40 EPS. On average, equities research analysts anticipate that HealthEquity, Inc. will post 2.32 earnings per share for the current year.

Insider Activity at HealthEquity

In other news, Director Robert W. Selander sold 5,750 shares of the business’s stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the sale, the director now owns 78,219 shares of the company’s stock, valued at $8,704,992.51. The trade was a 6.85 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Stuart B. Parker sold 25,000 shares of the business’s stock in a transaction on Thursday, December 12th. The stock was sold at an average price of $96.72, for a total value of $2,418,000.00. Following the sale, the director now owns 19,061 shares in the company, valued at approximately $1,843,579.92. The trade was a 56.74 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 39,000 shares of company stock worth $3,895,788 in the last three months. Insiders own 2.20% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on the stock. Mizuho started coverage on shares of HealthEquity in a research report on Wednesday, December 4th. They set an “outperform” rating and a $126.00 price objective for the company. Royal Bank of Canada boosted their price objective on HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research report on Tuesday, December 10th. BTIG Research upped their price objective on HealthEquity from $110.00 to $130.00 and gave the stock a “buy” rating in a research report on Thursday, November 14th. JMP Securities increased their price target on shares of HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a research note on Tuesday, December 10th. Finally, The Goldman Sachs Group began coverage on shares of HealthEquity in a research report on Friday, November 15th. They issued a “neutral” rating and a $108.00 price target for the company. One investment analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $110.71.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.